Esther Rheinbay
0000-0002-5566-6729
Publication & Citation Trends
Publications
0 total
Sensitive detection of somatic mutations in GC-rich cancer gene promoters OA
Cited by 0
Semantic Scholar
Breast Cancer Inequities: The Intersectional Role of Social Epidemiology and Tumor Biology
Cited by 2
Semantic Scholar
Abstract LB194: SIRT5 induces a metabolic switch to fuel nucleotide pools and chemoresistance in triple-negative breast cancer
Cited by 0
Semantic Scholar
A SIRT5-induced metabolic switch underlies chemoresistance and ATR checkpoint dependence in triple-negative breast cancer OA
Cited by 0
Semantic Scholar
Recurrent loss of chromosome y in multiple myeloma is linked to disease progression and altered tumor immune microenvironment
Cited by 0
Semantic Scholar
Abstract A033: Targeting ROR2 with an antibody-drug conjugate to overcome MYOD1L122R-driven therapy resistance in rhabdomyosarcoma
Cited by 1
Semantic Scholar
Abstract B035: Zebrafish modeling predicts clinical outcomes in human acute lymphoblastic leukemia
Cited by 0
Semantic Scholar
Abstract 4449: SIRT5 promotes chemoresistance through metabolic rewiring for nucleotide replenishing in refractory triple negative breast cancer
Cited by 0
Semantic Scholar
Lost but not least: Y chromosome loss as a driver of cancer.
Cited by 2
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(58)
Genomics and Chromatin Dynamics
(14)
Bioinformatics and Genomic Networks
(14)
Genetic factors in colorectal cancer
(13)
Epigenetics and DNA Methylation
(11)
Affiliations
Broad Institute
Boston University
University of Bern
National Institutes of Health
Howard Hughes Medical Institute
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.